These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 18795697

  • 1. Indocyanine green disappearance rate is the most useful marker for liver resection.
    Scheingraber S, Richter S, Igna D, Flesch S, Kopp B, Schilling MK.
    Hepatogastroenterology; 2008; 55(85):1394-9. PubMed ID: 18795697
    [Abstract] [Full Text] [Related]

  • 2. Indocyanine green elimination but not bilirubin indicates improvement of graft function during MARS therapy.
    Scheingraber S, Richter S, Igna D, Girndt M, Flesch S, Kleinschmidt S, Schilling MK.
    Clin Transplant; 2007; 21(6):689-95. PubMed ID: 17988260
    [Abstract] [Full Text] [Related]

  • 3. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure.
    de Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV.
    Eur J Surg Oncol; 2009 Sep; 35(9):957-62. PubMed ID: 19250796
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M.
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [Abstract] [Full Text] [Related]

  • 5. Pulse dye densitometry and indocyanine green plasma disappearance in ASA physical status I-II patients.
    Reekers M, Simon MJ, Boer F, Mooren RA, van Kleef JW, Dahan A, Vuyk J.
    Anesth Analg; 2010 Feb 01; 110(2):466-72. PubMed ID: 20081133
    [Abstract] [Full Text] [Related]

  • 6. Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation.
    Parker BM, Cywinski JB, Alster JM, Irefin SA, Popovich M, Beven M, Fung JJ.
    Liver Transpl; 2008 Jan 01; 14(1):46-52. PubMed ID: 18161838
    [Abstract] [Full Text] [Related]

  • 7. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
    Levesque E, Saliba F, Benhamida S, Ichaï P, Azoulay D, Adam R, Castaing D, Samuel D.
    Liver Transpl; 2009 Oct 01; 15(10):1358-64. PubMed ID: 19790157
    [Abstract] [Full Text] [Related]

  • 8. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M, Watanabe G.
    J Surg Res; 2000 Aug 01; 92(2):222-7. PubMed ID: 10896825
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of indocyanine green elimination assessed with LiMON in septic patients.
    Inal MT, Memiş D, Kargi M, Sut N.
    J Crit Care; 2009 Sep 01; 24(3):329-34. PubMed ID: 19327336
    [Abstract] [Full Text] [Related]

  • 10. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
    Lao XM, Zhang YQ, Lin XJ, Guo RP, Chen MS, Yuan YF, Li JQ, Li GH.
    Ai Zheng; 2005 Mar 01; 24(3):337-40. PubMed ID: 15757537
    [Abstract] [Full Text] [Related]

  • 11. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria.
    Kobayashi Y, Kiya Y, Nishioka Y, Hashimoto M, Shindoh J.
    HPB (Oxford); 2020 Feb 01; 22(2):258-264. PubMed ID: 31326264
    [Abstract] [Full Text] [Related]

  • 12. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À, Mas A, Fernández J, García-Valdecasas JC.
    Transplant Proc; 2012 Feb 01; 44(6):1539-41. PubMed ID: 22841207
    [Abstract] [Full Text] [Related]

  • 13. ICG pulse spectrophotometry for perioperative liver function in hepatectomy.
    Okochi O, Kaneko T, Sugimoto H, Inoue S, Takeda S, Nakao A.
    J Surg Res; 2002 Mar 01; 103(1):109-13. PubMed ID: 11855925
    [Abstract] [Full Text] [Related]

  • 14. Effects of propofol and dexmedetomidine on indocyanine green elimination assessed with LIMON to patients with early septic shock: a pilot study.
    Memiş D, Kargi M, Sut N.
    J Crit Care; 2009 Dec 01; 24(4):603-8. PubMed ID: 19931154
    [Abstract] [Full Text] [Related]

  • 15. Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.
    Mizuguchi T, Kawamoto M, Meguro M, Son S, Nakamura Y, Harada K, Shibata T, Ota S, Hirata K.
    Hepatogastroenterology; 2012 Dec 01; 59(114):551-7. PubMed ID: 22353523
    [Abstract] [Full Text] [Related]

  • 16. Preoperative hyaluronic acid measurement to assess the hepatic functional reserve.
    Suehiro T, Matsumata T, Shikada Y, Shimada M, Shirabe K, Sugimachi K.
    Hepatogastroenterology; 2004 Dec 01; 51(60):1776-9. PubMed ID: 15532824
    [Abstract] [Full Text] [Related]

  • 17. Incidence of early burn-induced effects on liver function as reflected by the plasma disappearance rate of indocyanine green: a prospective descriptive cohort study.
    Steinvall I, Fredrikson M, Bak Z, Sjoberg F.
    Burns; 2012 Mar 01; 38(2):214-24. PubMed ID: 22040928
    [Abstract] [Full Text] [Related]

  • 18. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse dye-densitometry.
    Sugimoto H, Okochi O, Hirota M, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A.
    J Hepatobiliary Pancreat Surg; 2006 Mar 01; 13(6):543-8. PubMed ID: 17139429
    [Abstract] [Full Text] [Related]

  • 19. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.
    Thomas MN, Weninger E, Angele M, Bösch F, Pratschke S, Andrassy J, Rentsch M, Stangl M, Hartwig W, Werner J, Guba M.
    HPB (Oxford); 2015 Jun 01; 17(6):471-6. PubMed ID: 25581073
    [Abstract] [Full Text] [Related]

  • 20. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M, Yogita S, Miyake H, Fukuda Y, Harada M, Wada D, Tashiro S.
    Hepatogastroenterology; 2002 Jun 01; 49(48):1625-31. PubMed ID: 12397750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.